Steffen Scheithauer

Title: Steffen Scheithauer: Innovator in Oral Pharmaceutical Compositions

Introduction

Steffen Scheithauer is a notable inventor based in Germany, recognized for his contributions to the field of pharmaceuticals. He has focused on developing oral dosage forms that enhance the delivery of active ingredients in medications. His innovative approach aims to improve patient outcomes through effective drug formulations.

Latest Patents

Steffen Scheithauer holds a patent for an "Oral Dosage Form For Propiverine Or Its Pharmaceutically Acceptable Salts With An Extended Release Of The Active Ingredient." This patent describes the production of oral pharmaceutical compositions containing propiverine or its pharmaceutically acceptable salts, with dosages ranging from 4 mg to 60 mg. The formulation is designed to provide a prolonged release of the active agent, utilizing a blend of the active ingredient and one or more acidic substances with a pKa value of less than 6.65. These compositions are either coated with a retarding layer or embedded in a matrix that may also be coated with additional retarding layers.

Career Highlights

Steffen Scheithauer is currently employed at Apogepha Arzneimittel GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective oral dosage forms that meet the needs of patients and healthcare providers alike.

Collaborations

Steffen has collaborated with notable colleagues, including Thomas Gramatte and Peter Gruber, who share his commitment to advancing pharmaceutical science.

Conclusion

Steffen Scheithauer's work in developing oral dosage forms represents a significant advancement in the pharmaceutical industry. His innovative formulations aim to enhance the efficacy of medications, ultimately benefiting patients worldwide.